| Ozgur Kilic |
Ozgur Kilic is currently working as the Chief Financial Officer & Director at AMAG Pharmaceuticals, Inc. He is also serving as the Treasurer at AMAG Pharma USA, Inc. |
| Michael Porter |
Michael Porter is currently the President, Chief Executive Officer & Director at AMAG Pharma USA, Inc., as well as the Chief Executive Officer at Covis Pharma Holdings BV, Covis Pharma US, Inc., and President & Director at AMAG Pharmaceuticals, Inc. Previously, he was the Chief Operating & Financial Officer at Covis Pharma Holdings SARL. He holds an MBA from Columbia Business School. |
| Anne M. Phillips |
Anne M. Phillips is an Independent Director at Trevena, Inc., Carmot Therapeutics, Inc., Vaccitech (UK) Ltd., Barinthus Biotherapeutics Plc, and vTv Therapeutics, Inc. She is also a Director at AMAG Pharmaceuticals, Inc. and a Fellow at the Royal College of Physicians & Surgeons of Canada. Previously, she served as a Director at the Biotechnology Innovation Organization and AMAG Pharmaceuticals, Inc. She was the Head of the Infectious Diseases Program at St. Michael's Hospital and the Senior VP of Clinical, Medical & Regulatory Affairs at Novo Nordisk, Inc. She also held positions as the Chief of Infectious Diseases and Associate Professor at Wellesley Hospital and as the Vice President of Medicine Development at GlaxoSmithKline LLC. Dr. Phillips holds a doctorate degree from the University of Toronto and an undergraduate degree from the University of Western Ontario. |
